Jesús Florián

Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer

Miguel Martín, Miguel Ángel Seguí, Antonio Antón et al. · New England Journal of Medicine · 2010 · 208 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer

Miguel Martín, Álvaro Rodríguez-Lescure, Emilio Alba et al. · Breast Cancer Research and Treatment · 2009 · 82 citations

Medicine, Oncology, Pharmacology +13

Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: efficacy and correlation with biological markers in a phase II, multicenter study.

Laura García‐Estévez, J. Cuevas, Antonio Antón et al. · PubMed · 2003 · 70 citations

Medicine, Oncology, Pharmacology +17

Docetaxel/Gemcitabine Administered Every Other Week as First-Line Treatment for Metastatic Breast Cancer: Final Results of a Phase II Trial

A. Pelegrí, Lourdes Calvo, Antonio Antón et al. · Clinical Breast Cancer · 2005 · 22 citations

Medicine, Oncology, Pharmacology +14

Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: Preliminary results from a phase II trial

Lourdes Calvo, José Mayordomo, Jesús Florián et al. · Seminars in Oncology · 2004 · 17 citations

Medicine, Oncology, Pharmacology +13